Boston Scientific Announces Recommended Offer to Acquire BTG plc.
MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offe
U.S. Crude Oil Inventories Fell by 3.9M Barrels Last Week: EIA...
U.S. Crude Oil Inventories Fell by 3.9M Barrels Last Week: EIA
Sandoz drives differentiated portfolio with deal to commercialize new treatment for...
(GLOBE NEWSWIRE via COMTEX) -- Novartis International AG / Sandoz drives differentiated portfolio with deal to commercialize new treatment fo
Excelsior Mining Corp – Excelsior Mining Secures US$75 Million Project Financing...
Excelsior is developing the Gunnison Copper Project, a low cost in-situ recovery copper project located within the copper porphyry belt of Arizona.
West Kirkland Reports That Permitting at Hasbrouck Gold Project, Nevada on...
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
Infosys Opens Technology and Innovation Hub in North Carolina, Hires 4,700...
The North Carolina hub will help Infosys work more closely with clients in the region in areas as Machine Learning, Artificial Intelligence, user experience and advanced digital technologies, including big data and Cloud, the company said in a statement late on Wednesday
Mawson Options Large Epithermal Gold Project in the USA, Commences Drilling
VANCOUVER, Nov. 5, 2018 /PRNewswire/ - Mawson Resources Limited ("Mawson") or (the "Company") (TSX:MAW) (Frankfurt:MXR) (PINKSHEETS: MWSNF) is please
AveXis Presents Data Showing Efficacy Of Zolgensma In Broad Spectrum Of...
AveXis, a Novartis company, announced interim data from ongoing trials of the investigational product Zolgensma or onasemnogene abeparvovec-xioi; AVXS-101 that showed positive results across a broad spectrum of patients with spinal muscular atrophy or SMA.
Sun Pharma Launches Ready-to-Infuse INFUGEM in the U.S. | Business Wire
Sun Pharma launches ready-to-infuse INFUGEM - the first and only chemotherapy product in a premixed, ready-to-infuse formulation - in the US.
Baillie Gifford willing to invest more in Tesla, praises CEO Elon...
Baillie Gifford, which holds a 7.72 percent stake in Tesla, called CEO Elon Musk an entrepreneur of "vision and ambition, who's working towards a social good."


















